CSS
GRCL

Cubist Systematic Strategies’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Cubist Systematic Strategies’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-59,063
Closed -$593K – 2949
2023
Q4 		$593K Buy
59,063
+57,656
+4,098% +$579K ﹤0.01% 1317
2023
Q3 		$4.05K Sell
1,407
-1,671
-54% -$4.81K ﹤0.01% 1848
2023
Q2 		$11.7K Sell
3,078
-9,333
-75% -$35.6K ﹤0.01% 2051
2023
Q1 		$23.1K Buy
+12,411
New +$23.1K ﹤0.01% 2617